BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Business

  metaLinear Secures 255K Pound Seed Investment for Targeted Antibacterial Research

  The new investment was secured from the BioCity Group, who manage the Alderley Park Ventures fund and Catapult Ventures, who manage the GM&C Life Sciences Fund.

  November 22, 2017

   · 

  2 min read
• Business

  AroCell AB: Reporting Period 1 July - 30 September 2017

  Sales for the period were 0 (46). Expenses were 3,678 (2,590).

  November 22, 2017

   · 

  8 min read
• Business

  SCIEX and NUS Faculty of Science Announce Plans to Launch New Training Centre for Proteomics and Mass Spectrometry Across Asia Pacific

  PPC and SCIEX have established a strong partnership since the inauguration of PPC at NUS Faculty of Science in 2000.

  November 22, 2017

   · 

  5 min read
• Pharm Country

  Quadrant Biosciences Release: Salivary microRNA May Predict Duration and Nature of Concussion Symptoms Among Children

  Small molecules in saliva may hold the key to predicting the type and duration of concussion symptoms, according to a study just published in the JAMA.

  November 22, 2017

   · 

  4 min read
• 

  Policy

  Portola Pharmaceuticals Provides Update on Bevyxxa (betrixaban) Commercial Launch

  The new action date is January 30, 2018.

  November 22, 2017

   · 

  6 min read
• Drug Development

  GENFIT: Positive Outcome From the 18-month Pre-Planned Safety Review by the DSMB, in RESOLVE-IT Phase III Clinical Trial With elafibranor

  NASH being considered as a chronic condition, safety is crucial for any drug candidate aiming to address the unmet clinical needs related to this pathology.

  November 22, 2017

   · 

  4 min read
• Drug Development

  First Patients Enter TARGET Study, Recently Initiated by Cerenis Therapeutics to Evaluate HDL Nanoparticles in Patients with Esophageal Cancer

  TARGET is the first ever performed clinical study testing the potential of labelled HDL to visualize tumors in cancer patients.

  November 22, 2017

   · 

  8 min read
• Biotech Beach

  MabVax Announces Adjournment of Special Meeting of Stockholders

  The Special Meeting has been adjourned to 11:00 a.m. Pacific Standard Time/2:00 p.m. Eastern Standard Time on Friday, December 1, 2017, at the offices of the Company at 11535 Sorrento Valley Road, Suite 400, San Diego, CA 92121.

  November 22, 2017

   · 

  8 min read
• Business

  Sinovac Files 2016 Annual Report on Form 20-F and Reports Unaudited Fourth Quarter 2016 Financial Results

  Quarterly sales from continuing operations were $31.4M compared to $23M in the prior year period, an increase of 36.7%.

  November 22, 2017

   · 

  56 min read
• Tetra Bio-Pharma’s Business Model and Commercialization Strategy in Line With the Canadian Government’s Proposed Approach to the Regulation of Cannabis

  The proposed approach to regulation recommends that cannabis-based health products are still subject to scientific review and must show significant efficacy, meet strict safety requirements and be of sufficient quality in order to gain market approval as a drug or as a natural health product.

  November 22, 2017

   · 

  5 min read